Cartesian Therapeutics Price Chart
Cartesian Therapeutics Volume Chart
Cartesian Therapeutics Market Segments
Regular Trading Hours
-0.03(-0.41%)
| Open | $7.40 |
|---|---|
| Close | $7.37 |
| Low | $7.31 |
| Low Change | -0.09 (-1.22%) |
| High | $7.63 |
| High Change | +0.23 (+3.11%) |
| Range | $0.32 |
| Volume | 15.646K |
| Dollar Volume | $115.31K |
Premarket
*No Trades in Segment
After Hours Yesterday
*No Trades in Segment
Regular Trading Hours Yesterday
-0.16(-2.13%)
| Open | $7.51 |
|---|---|
| Close | $7.35 |
| Low | $7.32 |
| Low Change | -0.19 (-2.53%) |
| High | $7.97 |
| High Change | +0.46 (+6.13%) |
| Range | $0.65 |
| Volume | 65.484K |
| Dollar Volume | $481.31K |
Premarket Yesterday
*No Trades in Segment
Cartesian Therapeutics Moving Averages
| 5 Day Moving Average (SMA5) | $7.93 |
|---|---|
| 10 Day Moving Average (SMA10) | $7.77 |
| 20 Day Moving Average (SMA20) | $7.54 |
| 50 Day Moving Average (SMA50) | $7.29 |
| 100 Day Moving Average (SMA100) | $7.45 |
| 200 Day Moving Average (SMA200) | $9.12 |
Cartesian Therapeutics Statistics
| Average Volume (30 Days) | 233.4K |
|---|---|
| P/E Ratio (Current) | -1.45 |
| EPS (Current) | -$5.11 |
| Dividend Yield | 0.00% |
| Free Cash Flow | -$79.40M |
| Cash Ratio | 8.38 |
| Current Ratio | 8.65 |
| Quick Ratio | 8.65 |
| Debt to Equity | 0.00 |
| Enterprise Value | $67.03M |
| EV to EBITDA | -0.80 |
| EV to Sales | 23.96 |
| Price to Book | -1.52 |
| Price to Cash Flow | — |
| Price to Free Cash Flow | — |
| Price to Sales | 68.70 |
| Return on Assets | -0.45% |
| Return on Equity | 1.05% |
Cartesian Therapeutics Stock Splits
There have been 2 stock splits for Cartesian Therapeutics (RNAC). The last reverse stock split occured on April 5, 2024 and reduced the outstanding shares at a ratio of 30:1.
| Date | Type | Ratio |
|---|---|---|
| Apr 5, 2024 | Reverse | 30:1 |
| Dec 1, 2023 | Forward | 1:2 |
Cartesian Therapeutics Dividends
There have been no dividends for Cartesian Therapeutics (RNAC).